CORC

浏览/检索结果: 共20条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Treatment of Chronic Hepatitis B Virus Infection Using Small Molecule Modulators of Nucleocapsid Assembly: Recent Advances and Perspectives 期刊论文
ACS INFECTIOUS DISEASES, 2019, 卷号: 5, 期号: 5, 页码: 713-724
作者:  Yang, Li;  Liu, Feifei;  Tong, Xiankun;  Hoffmann, Daniel;  Zuo, Jianping
收藏  |  浏览/下载:24/0  |  提交时间:2020/07/01
HCV core antigen is a useful predictor during pegylated-interferon/ribavirin therapy in patients with hepatitis C virus genotype 1b 期刊论文
2019, 卷号: 98, 期号: 10
作者:  Fan, Zhijuan;  Liu, Junfeng;  Wang, Fengmei;  Liu, Jingmin;  Ding, Xian
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/03
Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B 期刊论文
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2018, 卷号: 6, 期号: 1
作者:  Zhang, Wenhong;  Zhang, Dazhi;  Dou, Xiaoguang;  Xie, Qing;  Jiang, Jiaji
收藏  |  浏览/下载:50/0  |  提交时间:2019/12/05
Efficacy of Pegylated Interferon alpha-2a Therapy for HBsAg <= 1500 IU/Ml CHB Patients with a Prior Nas History 会议论文
作者:  Wu, Fengping;  Li, Yaping;  Li, Mei;  Wang, Wenjun;  Jia, Xiaoli
收藏  |  浏览/下载:8/0  |  提交时间:2019/11/19
Comparison of hepatitis B virus core-related antigen and hepatitis B surface antigen for predicting HBeAg seroconversion in chronic hepatitis B patients with pegylated interferon therapy 期刊论文
Infectious Diseases, 2018, 卷号: Vol.50 No.7, 页码: 522-530
作者:  Wang, ML;  Liao, J;  Wei, B;  Zhang, DM;  He, M
收藏  |  浏览/下载:10/0  |  提交时间:2019/02/28
Pegylated Interferon Alfa-2b Add-on Treatment in Hepatitis B Virus Envelope Antigen-Positive Chronic Hepatitis B Patients Treated with Nucleos(t) ide Analogue: A Randomized, Controlled Trial (PEGON) 期刊论文
JOURNAL OF INFECTIOUS DISEASES, 2017, 卷号: 215, 期号: 7
作者:  Chi, Heng;  Hansen, Bettina E.;  Guo, Simin;  Zhang, Ning Ping;  Qi, Xun
收藏  |  浏览/下载:15/0  |  提交时间:2019/12/05
Recent developments in antivirals against hepatitis B virus 期刊论文
VIRUS RESEARCH, 2016, 卷号: 213, 页码: 205-213
作者:  Wang, Ya-Juan;  Yang, Li;  Zuo, Jian-Ping
收藏  |  浏览/下载:23/0  |  提交时间:2019/01/08
Sustained immune control in HBeAg-positive patients who switched from entecavir therapy to pegylated interferon-alpha 2a: 1 year follow-up of the OSST study 期刊论文
Antiviral therapy, 2016, 卷号: 21, 期号: 4, 页码: 337-344
作者:  Han, Meifang;  Jiang, Jiaji;  Hou, Jinlin;  Tan, Deming;  Sun, Yongtao
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/03
Sequential Combination Therapy with Pegylated Interferon Leads to Loss of Hepatitis B Surface Antigen and Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Entecavir Treatment 期刊论文
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 卷号: 59, 期号: 7
作者:  Li, Guo-Jun;  Yu, Yi-Qi;  Chen, Shao-Long;  Fan, Ping;  Shao, Ling-Yun
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/19
康氏抗纤方联合干扰素、利巴韦林治疗慢性丙型肝炎33例临床观察 期刊论文
2014
梁惠卿; 杨嘉恩; 唐金模; 吴春城; 陈少东; 林莉
收藏  |  浏览/下载:3/0  |  提交时间:2016/05/17


©版权所有 ©2017 CSpace - Powered by CSpace